https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Beijing, China. en Sat, 07 Nov 2026 03:45:11 GMT https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12889-026-29178-z-9dc3ad3f/ https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12889-026-29178-z-9dc3ad3f/ Fri, 04 Sep 2026 00:00:00 GMT Mapping temporal disruptions and predictive markers enables health authorities to refine resource allocation, emphasizing expanded molecular testing and grassroots screening initiatives to streamline regional disease management. Tuberculosis COVID-19 Diagnostics Journal article https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108777-181987b1/ https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108777-181987b1/ Sat, 01 Aug 2026 00:00:00 GMT Vaccination retained value in outbreak-prone school environments despite antigenic drift and intense exposure, supporting continued school immunization and strain optimization. Influenza Vaccination Vaccine effectiveness Outbreak investigation Surveillance Transmission dynamics Journal article https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108381-462d9556/ https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108381-462d9556/ Sun, 01 Mar 2026 00:00:00 GMT The findings provide comparative clinical and prognostic information for adults hospitalized with RSV, influenza A, or co-infection in this single Beijing hospital. The authors indicate that the observed differences support consideration of infection-specific preventive and therapeutic strategies, including RSV vaccination; the abstract does not establish effects in other settings or populations. Influenza Treatment Vaccination Journal article https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-126836-47b795f5/ https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-126836-47b795f5/ Sat, 01 Mar 2025 00:00:00 GMT Authors argue that raising coverage in high-risk groups and scheduling boosters within 12 months could reduce disease and societal burden. COVID-19 SARS Vaccination Vaccine effectiveness Outbreak investigation Health policy Cohort study https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2024-106254-832ec75a/ https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2024-106254-832ec75a/ Tue, 01 Oct 2024 00:00:00 GMT The report shows RTE food contamination risk and supports reinforced control, surveillance, and education to lower infection risk. Listeriosis Genomic epidemiology Climate and environment Outbreak investigation Surveillance Genomic study https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09273-5-56259065/ https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09273-5-56259065/ Fri, 19 Apr 2024 00:00:00 GMT Laboratory-based monitoring is advised to track V. furnissii and limit spread of resistance genes, as the pathogen was more common than expected in summer. Gastroenteritis Antimicrobial resistance Genomic epidemiology Surveillance Genomic study https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-021-06872-4-d064b840/ https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-021-06872-4-d064b840/ Tue, 04 Jan 2022 00:00:00 GMT The authors reported that incorporating molecular epidemiology into routine surveillance in a low-prevalence setting could help identify possible outbreak clusters and support earlier control of hepatitis A transmission. Hepatitis A Surveillance Transmission dynamics Outbreak investigation Journal article https://papers.globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30843-4-670e007c/ https://papers.globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30843-4-670e007c/ Mon, 01 Feb 2021 00:00:00 GMT The data suggest that a reduced antigen formulation could balance immunological response with manufacturing efficiency, warranting further investigation in larger efficacy studies. SARS COVID-19 Vaccination Treatment Vaccine safety Climate and environment Randomised controlled trial https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6821a3-c2710c58/ https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6821a3-c2710c58/ Fri, 31 May 2019 00:00:00 GMT The report points to a potential means of expanding HIV testing among a stigmatized key population in a country with low general prevalence, as tagged by disease and location classifiers. HIV infection AIDS Treatment Journal article https://papers.globalinfectiousdisease.com/research/articles/10-1017-s0950268812000027-b2f47d58/ https://papers.globalinfectiousdisease.com/research/articles/10-1017-s0950268812000027-b2f47d58/ Tue, 27 Mar 2012 00:00:00 GMT The findings clarify that GBV-C viraemia is not protective against HIV-1 acquisition and that HIV-1 infection increases GBV-C prevalence, informing understanding of co-infection dynamics in MSM populations. HIV infection Hepatitis C Transmission dynamics Cohort study https://papers.globalinfectiousdisease.com/research/articles/10-1086-652143-e03ad8e4/ https://papers.globalinfectiousdisease.com/research/articles/10-1086-652143-e03ad8e4/ Sat, 15 May 2010 00:00:00 GMT The findings describe cocirculation and competitive transmission dynamics of pandemic and seasonal influenza A in a closed setting, which is relevant to outbreak preparedness and antiviral stewardship considerations during pandemic waves. Influenza Outbreak investigation Transmission dynamics Outbreak investigation